Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Forex Boards   25/11/2009 14:55:10 Site map   Help   Financials Sector Sheet Search by Sector FilterX For help & enquiries: 1-888-99-ADVFN (toll free)

York Pharma Company Financial Information York Pharma share price | York Pharma company information | York Pharma Share Charts | York Pharma Share News  Company name:  York Pharma  EPIC:  YRK (delisted)  Trading Currency:  GBX  Market Sector:  AIMT  ISIN:  GB00B00QHC86  Market Segment:  AIMI  Share Type:  DE  WWW Address:  http://www.yorkpharma.com/  Description:  ORD 5P  Industry Sector:  PHARMACEUTICALS & BIOTECHNOLOGY  Price  Price Change [%]  Bid  Ask  Open  High  Low  Volume  3.25   0.0 [0.00]  -  -  -  -  -  -  Market Cap. [m]  Shares In Issue [m]  Beta  EPS  DPS  PE Ratio  Yield  52-Wks-Range  2.00  61.40  1.75  -  -  -  -  - York Pharma Key Figures (at previous day's close) Market Cap. 2.00 m Shares In Issue 61.40 m Prev. Close 3.25 PE Ratio -   Dividend Yield - % EPS - basic - p Dividend PS - p Dividend Cover -   Cash Flow PS - p Return On Equity (ROE) - % Operating Margin - % PEG Factor -   EPS Growth Rate - % Dividends PS Growth Rate - % Net Debt - m Gross Gearing - % Quick Assets - m Net Working Capital - m Intangibles / Fixed Assets - % Turnover PS - p Pre-Tax Profit PS - p Retained Profit PS - p Cash PS - p Net Cash PS - p Net Tangible Asset Value PS * - p Net Asset Value PS - p Spread - (-%)   * Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies. York Pharma Balance Sheet Sorry No Data Available York Pharma Share Price %1$s Share Price York Pharma Share Price (5 years) York Pharma Historic Returns %1$s Historic Returns York Pharma Key Management Ratios York Pharma Investment Ratios (Market value analysis) at previous day's close PQ Ratio -   PE Ratio -   Tobin's Q Ratio -   Tobin's Q Ratio (excl. intangibles) -   Dividend Yield - % Market-to-Book Ratio -   Price-to-Pre-Tax Profit PS -   Price-to-Retained Profit PS -   Price-to-Cash Flow PS -   Price-to-Sales PS -   Price-to-Net Tangible Asset Value PS -   Price-to-Cash PS -   Net Working Capital PS -   Price Pct to Working Capital PS - % Earnings Yield - % Average PE -   Years in average -   PE to PE average - % York Pharma Financial Ratios (Leverage Ratios) Debt Ratio - % Debt-to-Equity Ratio -   Debt-to-Equity Ratio (excl. Intgbl) -   Debt-to-Equity Market Value -   Net Gearing - % Net Gearing (excl. Intangibles) - % Gross Gearing - % Gross Gearing (excl. Intangibles) - % Gearing Under 1 Year - % Gearing Under 1 Year (excl. Intgbl) - % Assets/Equity -   Cash/Equity -   (Liquidity Ratios) Net Working Capital to Total Assets - % Current Ratio -   Quick Ratio (Acid Test) -   Liquidity Ratio -   Cash & Equiv/Current Assets - % (Solvency Ratios) Enterprise Value 2.00 m CFO/Sales -   CFO/Attributable Profit -   CFO/Assets -   CFO/Debt -   Total Debt/Equity Market Value -   Total Debt/Sales -   Total Debt/Pre-Tax Profit -   Total Debt - m Total Debt/Net Current Assets - % (Dodds - Graham Ratios) 3 yr Compound Earnings Growth - % 5 yr Compound Earnings Growth - % 10 yr Compound Earnings Growth - % Earn drops > 5% in 10yrs -   Beta (60-Mnth) Beta (36-Mnth) 1.7480 1.4858 Alpha (60-Mnth) Alpha (36-Mnth) -0.0410 -0.0773 York Pharma Operating Ratios (Profitability Ratios) Return On Capital Employed (ROCE) - % Return On Assets (ROA) - % Net Profit Margin - % Assets Turnover -   Return On Equity (ROE) - % Return On Investment (ROI) - % Dividend Payout Ratio - % Plowback Ratio 100.00 % Growth from Plowback Ratio - % Net Income Of Revenues - % (Asset Utilisation Multiples) Shareholders Equity Turnover -   Fixed Assets Turnover -   Current Assets Turnover -   Net Working Capital Turnover -   Inventory Turnover -   (Other Operating Ratios) Total Assets-to-Sales -   Debtors-to-Sales - % Debt Collection Period - Days York Pharma Dividends %1$s Dividends York Pharma Fundamentals Profit and Loss Account York Pharma Balance Sheet %1$s Balance Sheet York Pharma Cash Flow Statement %1$s Cash Flow Statement York Pharma Brokers Name Activity Type Mnemonic Code Collins Stewart Ld Market Maker(MMF) Broker/Dealer CSCS CSTEGB21 Kbc Peel Hunt Ld Market Maker(MMF) Broker/Dealer KBC KBCSGB21BIC Shore Capital Stockbrokers Ld Market Maker(MMF) Broker/Dealer SCAP SHOCGB21 Teather & Greenwood Ld Market Maker(MMF) Broker/Dealer TEAM TGREGB21 Winterflood Secs Ld Market Maker(MMF) Broker/Dealer WINS WNTSGB2LBIC

LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes. All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

ADDITIONAL SERVICES AVAILABLE FROM ADVFN ADVFN Forex Channel Exchange Rates, FX Prices Charts, Forex Brokers & Currency Conversion

31 site:2us lse yrk091125 14:55 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )